Location History:
- Falcon Heights, MN (US) (2023)
- Minneapolis, MN (US) (2023)
Company Filing History:
Years Active: 2023
Title: Maciej Maselko: Innovator in Programmable Transcription Factors
Introduction
Maciej Maselko is a prominent inventor based in Falcon Heights, MN (US). He has made significant contributions to the field of biotechnology, particularly in the development of programmable transcription factors. With a total of 2 patents, his work is paving the way for advancements in genetic engineering and biocontrol systems.
Latest Patents
Maselko's latest patents include innovative technologies that enhance the capabilities of transcription factors. The first patent, titled "Programmable transcription factors and methods," describes a system that includes a programmable transcription factor, a polynucleotide with a coding region, and a promoter linked to the polynucleotide. This system allows for precise control over gene expression, either activating or repressing transcription based on the product encoded by the polynucleotide.
The second patent, "Biocontainment/biocontrol system and methods," outlines a biocontainment system that utilizes a coding region whose overexpression can decrease cell growth. This system is designed to operate based on the presence or absence of a silent mutation, allowing for controlled gene expression that can prevent unwanted growth in engineered cells.
Career Highlights
Maciej Maselko is affiliated with the University of Minnesota, where he conducts research and develops his innovative technologies. His work is instrumental in advancing the understanding of transcription factors and their applications in biotechnology.
Collaborations
Maselko collaborates with notable colleagues, including Michael Joseph Smanski and Mike Smanski. These partnerships enhance the research and development of his patented technologies, contributing to the broader scientific community.
Conclusion
Maciej Maselko's contributions to the field of biotechnology through his patents on programmable transcription factors and biocontainment systems highlight his role as an innovative inventor. His work continues to influence advancements in genetic engineering and biocontrol methods.